DOMS IndustriesQ1 FY25

DOMS Industries Q1 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹2,043.8P/E: 60.9Market Cap: ₹12.4K CrSector: Household Products

Management growth scorecard

Revenue

Category 2

Margin

Category 4

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2
  • The company targets about 20% core business revenue growth in FY25, with additional growth from inorganic acquisitions (e.g., Uniclan).
  • Office supplies like pens have a growing production capacity, with pen manufacturing capacity recently expanded to 3 million pens/day and plans to increase pencil capacity by about 2.5 million/day soon.
  • The new pen production unit (1 million pens/day capacity) started operations towards end of June 2024 and utilization will steadily increase.
  • The diaper business (Uniclan acquisition) is expanding capacity from 400 million to 650 million pieces/year, expected to contribute to growth.
  • The company focuses primarily on the domestic market for expansion; international sales are currently stable but expected to improve with increased manufacturing capacity.
  • New product launches (e.g., SKIDO brand, new SKUs in pens) and capacity additions are expected to drive volume and sales growth organically.
  • Overall, management is optimistic to achieve close to 20-25% top-line growth.

See what DOMS Industries management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes
  • DOMS Industries is currently infusing approximately INR 29 crores as primary infusion in Uniclan as part of their acquisition, with the balance being secondary purchase from existing promoters (Page 12).
  • This primary infusion will support Uniclan's capital requirements for mid-term, including capital expenses for expanding diaper manufacturing capacity and starting the wet wipe segment (Page 12).
  • The current net debt level of Uniclan is about INR 38 crores. Post-capital infusion, some of the infusion will be used for capex and working capital (Page 12).
  • The company did not mention any specific plans for fresh fundraising through debt or equity beyond this acquisition infusion.
  • DOMS plans organic capacity expansions funded primarily through internal accruals—INR 35 crores spent on capex in Q1 FY25 for pen capacity and ongoing projects (Page 3).
  • No explicit mention of additional equity or debt fundraising in near future beyond these planned investments was stated.

See what DOMS Industries management said on order book — free account, 30 seconds.

Capex plans

Yes
  • DOMS is expanding manufacturing capacities, including a new 44-acre land parcel under construction since Q1 2024 for core stationery products.
  • Recently commercialized an additional pen manufacturing capacity of 1 million pens per day, increasing total capacity to 3 million pens/day soon.
  • Plans to add pencil manufacturing capacity by end of FY25 or early FY26, increasing from 5.7 million to about 8-8.5 million pieces per day.
  • Acquisition of Uniclan (diaper business) includes a capital infusion of approx. INR 29 crores planned for capacity expansion (adding a third diaper manufacturing line with 250 million pieces/year capacity) and wet wipes segment.
  • Future inorganic expansions in unrelated categories (e.g., toys, baby care) are planned; core stationery capacity growth will continue organically.
  • Capital expenditure in Q1 FY25 was around INR 35 crores, mainly on plant machinery, equipment, and construction related to pens and 44-acre land parcel.

Track DOMS Industries — get its next earnings analysis in your feed

How does DOMS Industries rank vs peers in Household Products?

Pro feature
ThisDOMS Industries
Rev 2Mar 4

How does DOMS Industries rank in Household Products?

Compare DOMS Industries against every Household Products company (Q1 FY25) on revenue, margins and earnings-call signals.

View Household Products leaderboard →

Others in Household Products this season

  • Sundaram Multi Pap (Q2 FY27)

    316.55 Lacs (approximately 12.16%) . Key results statement takeaways from Sundaram Multi Pap Ltd's Q2 FY27 results statement — and how it ranks against sector p

  • Vasa Retail (Q2 FY27)

    . Key results statement takeaways from Vasa Retail and Overseas Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

  • Indo National (Q2 FY27)

    825.77 lakhs (~6.9% growth) . Key results statement takeaways from Indo National Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

  • Ambica Agarbathies Aroma & Industries (Q2 FY27)

    Quarter ended 30th Sep 2026 revenue (Net Sales/Income from Operations): ₹4,023.40 lakhs (Page 2). Key results statement takeaways from Ambica Agarbathies Aroma

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →